Hem › Äggstockscancer › Rhode Island › Providence
Kliniska studier för Äggstockscancer i Providence, RI
15 studier för Äggstockscancer söker deltagare vid platser i och runt Providence (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekryterarFas 2
- Women and Infants Hospital, Providence
- Roger Williams Medical Center, Providence
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RekryterarFas 1/2
- Research Site, Providence
TLR9 Immunotherapy for Peritoneal Carcinomatosis
RekryterarFas 1
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
RekryterarFas 2
- Women & Infants Hospital /ID# 277930, Providence
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RekryterarFas 2
- Women & Infants Hospital /ID# 274716, Providence
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekryterarFas 3
- Women & Infants Hospital, Providence
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
RekryterarFas 3
- Women & Infants Hospital ( Site 0001), Providence
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RekryterarFas 3
- Women & Infants Hospital ( Site 0050), Providence
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekryterar
- Women and Infants Hospital, Providence
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekryterarFas 3
- Women and Infants Hospital, Providence
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekryterarFas 1/2
- Women and Infants Hospital of Rhode Island, Providence
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekryterarFas 2
- Lifespan Cancer Institute - Rhode Island Hospital, Providence
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
RekryterarFriska volontärer välkomna
- Women's and Infant's Hospital, Providence
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
RekryterarFas 1
- Site 0191, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Providence
Äggstockscancer-studier i andra städer
- Houston, TX89 studier
- New York City, NY69 studier
- Boston, MA61 studier
- Los Angeles, CA50 studier
- Nashville, TN49 studier
- Arlington, VA46 studier
- Philadelphia, PA44 studier
- Columbus, OH39 studier
- St. Louis, MO38 studier
- Chicago, IL36 studier
- San Antonio, TX31 studier
- Cleveland, OH30 studier
Andra studier i Providence
- Endometriecancer14 studier
- Övervikt14 studier
- Icke-småcellig lungcancer12 studier
- Cancer (alla typer)12 studier
- Crohns sjukdom12 studier
- Bröstcancer11 studier
- Ulcerös kolit11 studier
- Akut myeloid leukemi10 studier
- Metastaserande cancer9 studier
- Övervikt9 studier
- Alkoholmissbruk (AUD)8 studier
- Alzheimers sjukdom8 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.